ArticleFrontiers in artificial intelligence2026
Using transfer learning approaches to predict RNA-Seq gene expression data for cancer classification.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a great need to categorize cancer types for early cancer detection and treatment. RNA-Seq data is essential for getting insight into the differentially expressed genes. Due to its high dimensionality and complexity, performing an analysis on RNA-Seq data is quite challenging. In the past, RNA-Seq data were analyzed for a single cancer type as a two-class problem (either positive or negative) and did not contain information from other classes of cancer types. To classify different cancer types and discover the most promising genes, RNA-Seq data for different types of cancer should be examined. Multiple repositories offer RNA-Seq-based cancer types data. The present study incorporates a dataset from the Mendeley repository for classification. RNA-Seq values are then converted to their respective 2D images using some transformations. The classification problem is handled by five Transfer Learning (TL) algorithms (VGG16, VGG19, Resnet50, Resnet101, and Resnet152). Four different splitting strategies are applied for each classifier presented in the results and discussion section. A comparative analysis is also carried out with and without data augmentation. Results show that classifiers perform best at a split of 70-30. VGG16 attained the best position on overall results by achieving an accuracy of 95%. Hence, VGG16 is the leading TL algorithm for classification among all the accessible models and is not difficult to execute and easy to comprehend.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.